Evaluation of user’s perspective on readability and understanding of medicine package inserts
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20232363Keywords:
Barriers, Misinterpretation, MPI, Readability, User centred approachAbstract
Background: Aim of this study was to evaluate the user’s perspective on readability and understanding of Medicine package inserts (MPIs).
Methods: A cross-sectional study was conducted in the community pharmacy settings, encompassing participants from urban and rural areas of Pune, Mumbai, and Thane districts. The user’s ability to read and understand was assessed using a 3-point Likert scale and was correlated to their socio-demographic characteristics using Pearson’s coefficient. Also, the difference in the means between the groups was analysed using the student’s test. A p-value ≤0.05 was considered statistically significant.
Results: Out of 502 respondents, most of the participants had the habit of reading MPI (51.3%). Although, on correlating the level of difficulty to the participant's socio-demographic characteristics, a little difficulty in reading (57.8%) and understanding (60%) of instructions respectively were reported in participants of the age group: 38-57 years (57%; 60%), who were graduate (70.2%; 69.8%), and was significantly associated to their area of residence (p<0.5). Addressing the language barrier and providing MPI in their native language increased participants’ readability by a whopping 57%, who earlier stated ‘difficulty to read (70.49%)’ as the major factor to not refer MPIs.
Conclusions: More than half the respondents (51.4%) usually read the MPI. Nonetheless, people stated that they faced difficulty in reading and understanding it. Diversifying this data by age and level of education can help policymakers ensure a user-directed upgrade of the package inserts and implement patient education in the users’ native language by healthcare providers such as pharmacists.
References
Pires C, Vigário M, Cavaco A. Factors influencing subjects’ comprehension of a set of medicine package inserts. Inter J Clin Pharm. 2016;38:888-98.
Shrank W, Avorn J, Rolon C, Shekelle P. Medication safety: Effect of content and format of prescription drug labels on readability, understanding, and medication use: A systematic review. Ann Pharmaco. 2007;41(5):783-801.
Ogundeko TO, Ogbole EA, Builders M, Akande T, Sokomba EN, Toma B, et al. Readability of drugs and chemicals package inserts information: a survey of the Nigerian market. World J Pharma Life Sci. 2017;4(5):12-6.
Ramdas D, Chakraborty A, Swaroop HS, Faizan S, Kumar P, Srinivas BN. A study of package inserts in southern India. JCDR. 2013;7(11):2475.
Law AV, Zargarzadeh AH. How do patients read, understand and use prescription labels? An exploratory study examining patient and pharmacist perspectives. Inter J Pharm Pract. 2010;18(5):282-9.
Pires CM, Cavaco AM. Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine. Euro J Clin Pharmacol. 2014;70:583-8.
Idris KA, Yousif MA, Elkhawad AO. Assessment of the readability, understandability, informational contents conformity and usefulness of medication package inserts to Sudanese patients. World J Pharma Sci. 2014;2(9):892-8.
Shivkar YM. Clinical information in drug package inserts in India. J Postgrad Med. 2009;55(2):104.
Adepu R, Swamy MK. Development and evaluation of patient information leaflets (PIL) usefulness. Ind J Pharma Sci. 2012;74(2):174.
European Commission Enterprise and Industry Directorate-Genera. Guideline on the readability of the label and package leaflet of medicinal products for human use, Revision 1, 2009. Available at: https://health.ec.europa.eu/system/files/2016-11/2009_01_12_readability_guideline_final_en_0.pdf. Accessed 20 December 2023.
Zarea Gavgani V, Mirzadeh-Qasabeh S, Hanaee J, Hamishehkar H. Calculating reading ease score of patient package inserts in Iran. Drug Healthc Pat Sa. 2018;10:9-19.
Fuchs J, Heyer T, Langenhan D, Hippius M. Influence of font sizes on the readability and comprehensibility of package inserts. Pharmaz Indust. 2008;70(5):584-92.
Idris KA, Yousif MA, Elkhawad AO. Medications package inserts’ usefulness to doctors and patients: Sudanese doctors perspective. Inter J Bas Clin Pharmacol. 2014;3(4):718-22.
Pizzol TD, Moraes CG, Arrais PS, Bertoldi AD, Ramos LR, Farias MR, et al. Medicine package inserts from the users’ perspective: are they read and understood?. Revi Brasil Epidemiol. 2019;22:e190009.
Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. DICP: Ann Pharmaco. 1991;25(9):1002–6.
Chhaya MU. Analysis of package inserts of orally administered drugs available in the Indian market. Int J Res Med Sci. 2017;5(2):529-32.
Gibbs S, Waters WE, George CF. Prescription information leaflets: a national survey. J Roy Soci Med. 1990;83(5):292–7.
Merges F, Nasiri S, Fathi M. Package Insert Leaflet Analysis and Improvement to Reduce Patient Risk Factors: A Pharmacovigilance Approach in Computer Science. In2014 IEEE 27th International Symposium on Computer-Based Medical Systems 2014 (pp. 483-484). IEEE.
